Diagnostic Enzymes in Myocardial Infarction
Author Information
Author(s): Samir M, Nagi H Khaled, Ragab D, Refaie M
Primary Institution: Cairo University
Hypothesis
The study aims to demonstrate the role of arginase and adenosine deaminase (ADA) in patients suffering from myocardial infarction and chronic renal failure with cardiovascular diseases.
Conclusion
ADA is a good diagnostic enzyme for patients suffering from myocardial infarction and chronic renal failure with cardiovascular diseases.
Supporting Evidence
- The mean serum arginase enzyme activity was significantly higher in myocardial infarction patients compared to the control group.
- ADA levels were also significantly elevated in myocardial infarction patients compared to controls.
Takeaway
Doctors can use certain enzymes to help diagnose heart attacks and kidney problems in patients.
Methodology
This was a prospective study including 90 subjects divided into three groups: myocardial infarction patients, chronic renal failure patients with cardiovascular diseases, and normal volunteers.
Participant Demographics
30 patients with myocardial infarction, 30 patients with chronic renal failure, and 30 normal volunteers.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website